Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251. | J Clin Oncol;19(20): 4014-22, 2001 Oct 15. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.

Lee, E J; Petroni, G R; Schiffer, C A; Freter, C E; Johnson, J L; Barcos, M; Frizzera, G; Bloomfield, C D; Peterson, B A.

Affiliation

Lee EJ; Department of Medicine, the Alvin and Lois Lapidus Cancer Institute, Sinai Hospital, Baltimore, MD, USA.

J Clin Oncol ; 19(20): 4014-22, 2001 Oct 15.

Article in En | MEDLINE | ID: mdl-11600602

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Antineoplastic Combined Chemotherapy Protocols / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Adult / Aged / Female / Humans / Male Language: En Journal: J Clin Oncol Year: 2001 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Antineoplastic Combined Chemotherapy Protocols / Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Adult / Aged / Female / Humans / Male Language: En Journal: J Clin Oncol Year: 2001 Document type: Article Affiliation country: Country of publication: